CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 1136270-1136674 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T73372","span":{"begin":0,"end":79},"obj":"Sentence"},{"id":"T68907","span":{"begin":80,"end":388},"obj":"Sentence"},{"id":"T90120","span":{"begin":389,"end":404},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"It is not yet known if APP or amyloid-β plays a role in the pathogenesis of MS. Histopathological evaluation of MS lesions has revealed that APP immunoreactivity is increased in active demyelinating plaques compared to control patients without neurological disease and that APP is induced on reactive glial cells, neurons, and T lymphocytes during demyelination (Gehrmann et al., Glia 15: 141-151,1995) ."}

{"project":"Epistemic_Statements","denotations":[{"id":"T2470","span":{"begin":0,"end":404},"obj":"Epistemic_statement"}],"text":"It is not yet known if APP or amyloid-β plays a role in the pathogenesis of MS. Histopathological evaluation of MS lesions has revealed that APP immunoreactivity is increased in active demyelinating plaques compared to control patients without neurological disease and that APP is induced on reactive glial cells, neurons, and T lymphocytes during demyelination (Gehrmann et al., Glia 15: 141-151,1995) ."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T8","span":{"begin":0,"end":79},"obj":"Sentence"},{"id":"T9","span":{"begin":80,"end":388},"obj":"Sentence"},{"id":"T10","span":{"begin":389,"end":404},"obj":"Sentence"}],"text":"It is not yet known if APP or amyloid-β plays a role in the pathogenesis of MS. Histopathological evaluation of MS lesions has revealed that APP immunoreactivity is increased in active demyelinating plaques compared to control patients without neurological disease and that APP is induced on reactive glial cells, neurons, and T lymphocytes during demyelination (Gehrmann et al., Glia 15: 141-151,1995) ."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T403","span":{"begin":185,"end":198},"obj":"Phenotype"},{"id":"T404","span":{"begin":348,"end":361},"obj":"Phenotype"}],"attributes":[{"id":"A403","pred":"hp_id","subj":"T403","obj":"http://purl.obolibrary.org/obo/HP_0011096"},{"id":"A404","pred":"hp_id","subj":"T404","obj":"http://purl.obolibrary.org/obo/HP_0011096"}],"text":"It is not yet known if APP or amyloid-β plays a role in the pathogenesis of MS. Histopathological evaluation of MS lesions has revealed that APP immunoreactivity is increased in active demyelinating plaques compared to control patients without neurological disease and that APP is induced on reactive glial cells, neurons, and T lymphocytes during demyelination (Gehrmann et al., Glia 15: 141-151,1995) ."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T4634","span":{"begin":76,"end":78},"obj":"Body_part"},{"id":"T4635","span":{"begin":112,"end":114},"obj":"Body_part"}],"attributes":[{"id":"A4634","pred":"uberon_id","subj":"T4634","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"},{"id":"A4635","pred":"uberon_id","subj":"T4635","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"}],"text":"It is not yet known if APP or amyloid-β plays a role in the pathogenesis of MS. Histopathological evaluation of MS lesions has revealed that APP immunoreactivity is increased in active demyelinating plaques compared to control patients without neurological disease and that APP is induced on reactive glial cells, neurons, and T lymphocytes during demyelination (Gehrmann et al., Glia 15: 141-151,1995) ."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T981","span":{"begin":30,"end":37},"obj":"Disease"},{"id":"T982","span":{"begin":76,"end":78},"obj":"Disease"},{"id":"T983","span":{"begin":112,"end":114},"obj":"Disease"},{"id":"T984","span":{"begin":244,"end":264},"obj":"Disease"},{"id":"T34053","span":{"begin":30,"end":37},"obj":"Disease"},{"id":"T52813","span":{"begin":76,"end":78},"obj":"Disease"},{"id":"T14656","span":{"begin":112,"end":114},"obj":"Disease"},{"id":"T22367","span":{"begin":244,"end":264},"obj":"Disease"}],"attributes":[{"id":"A981","pred":"mondo_id","subj":"T981","obj":"http://purl.obolibrary.org/obo/MONDO_0019065"},{"id":"A982","pred":"mondo_id","subj":"T982","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A983","pred":"mondo_id","subj":"T983","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A984","pred":"mondo_id","subj":"T984","obj":"http://purl.obolibrary.org/obo/MONDO_0005071"},{"id":"A20061","pred":"mondo_id","subj":"T34053","obj":"http://purl.obolibrary.org/obo/MONDO_0019065"},{"id":"A64934","pred":"mondo_id","subj":"T52813","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A68071","pred":"mondo_id","subj":"T14656","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A17226","pred":"mondo_id","subj":"T22367","obj":"http://purl.obolibrary.org/obo/MONDO_0005071"}],"text":"It is not yet known if APP or amyloid-β plays a role in the pathogenesis of MS. Histopathological evaluation of MS lesions has revealed that APP immunoreactivity is increased in active demyelinating plaques compared to control patients without neurological disease and that APP is induced on reactive glial cells, neurons, and T lymphocytes during demyelination (Gehrmann et al., Glia 15: 141-151,1995) ."}